Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-01-21 @ 10:57 AM
Study NCT ID:
NCT02607956
Status:
COMPLETED
Last Update Posted:
2022-03-07
First Post:
2015-11-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-10
First Submit QC Date:
None
Study First Post Date:
2015-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-03
Results First Submit QC Date:
None
Results First Post Date:
2018-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-10
Last Update Post Date:
2022-03-07
Last Update Post Date Type:
ACTUAL